Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars

Scientists One Step Closer to Less Invasive Test for Brain Cancer

By Kenny Walter | November 6, 2018

Researchers based in the U.K. are creating liquid biopsies for brain tumors by identifying tumor DNA in brain and spine fluid.

After analyzing cerebrospinal fluid (CSF), researchers from the Cancer Research UK Cambridge Institute, detected tumor DNA in 39 percent of 13 patients who had a type of brain tumor called a glioma.

Liquid biopsies are a less invasive way to monitor diseases, as opposed to tumor biopsies that are difficult and risky for patients. The team used a technique called shallow whole-genome sequencing to detect the brain tumor DNA and look for large genetic changes like genes being duplicated or lost.

“Liquid biopsies are showing great promise for a number of cancer types, but tests for brain tumours have lagged behind due to the low levels of tumour DNA found in body fluids, in particular the blood,” Florent Mouliere, PhD, co-first author, said in a statement.

“Our work shows that a cheap, easily available technique can be used to analyse tumour DNA in cerebrospinal fluid,” he added. “In the future, we envisage that this technique could be used to identify patients who may benefit from further tests that could help monitor their disease, opening up more tailored treatment approaches.”

The study represents the first time scientists were able to identify tumor DNA in CSF by looking at the size of the DNA fragments, which are generally shorter than those from healthy cells. This provides another method to detect brain tumor DNA and potentially increase the overall detection rate.

The researchers took multiple tissue samples from the brain tumor in one patient and compared it to that patient’s CSF. While the genetic changes matched, the CSF contained changes that were missed in some of the tissue samples, suggesting that CSF samples could reflect the repertoire of genetic alterations found in brain tumors.

According to the researchers, more than 11,400 people in the U.K. are diagnosed with brain tumors, with only 14 percent surviving the condition for more than 10 years.

“Survival for brain tumours remains low and there is an urgent need for research like this to identify strategies to better manage these complex diseases,” professor Charles Swanton, PhD, Cancer Research UK’s Chief Clinician, said in a statement. “This study lays important groundwork that brings the possibility of liquid biopsies for this hard to treat disease one step closer.

“The researchers will now need to expand this work into larger numbers of patients and find out whether this approach could have applications in the clinic, such as indicating whether a patient’s treatment is working,” he added.

The study was published in EMBO Molecular Medicine.

 

 

 

 

Related Articles Read More >

New dangers in the woods — and the hope that research offers us
Novel mass spectrometry solution simplifies insight gathering into macromolecular complexes
ENPICOM launches display solution to accelerate antibody selection while maximizing precision
Thermo Fisher Scientific autoimmune-testing instruments now available in the U.S.
2021 R&D Global Funding Forecast

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2022 Global Funding Forecast

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • COVID-19
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
      • Software
    • Semiconductors
  • 2021 R&D 100 Award Winners
    • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • Global Funding Forecast
  • Webinars